The results of the RNA-seq showed that 312 transcripts in the NFE2L3 knockdown group were downregulated, and 3 114 transcripts in the ccRCC tissue described above were upregulated. The gene discussed is NFE2L3; the disease is nonpapillary renal cell carcinoma.